Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
05.11.23 | Celldex Therapeutics, Inc.: Celldex Therapeutics Presents Positive Data from Prurigo Nodularis Phase 1b Study Demonstrating Meaningful Reduction in Itch and Skin Clearing with Single Dose 3.0 mg/kg Barzolvolimab | 202 | GlobeNewswire (Europe) | - Response observed as early as week 1 and durable for up to 16 weeks -- Data support important role for mast cells in the pathogenesis of PN and potentially other chronic itch indications -- Phase... ► Artikel lesen | |
05.11.23 | Tenaris SA: Tenaris to Commence a USD 300 million First Tranche of its USD 1.2 Billion Share Buyback Program | 611 | GlobeNewswire (Europe) | LUXEMBOURG, Nov. 05, 2023 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE and Mexico: TS and EXM Italy: TEN) ("Tenaris") announced today that pursuant to its Share Buyback Program (the "Program") announced on... ► Artikel lesen | |
05.11.23 | MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis | 600 | GlobeNewswire (Europe) | MoonLake Immunotherapeutics announces landmark Phase 2 results for Nanobody® sonelokimab in active psoriatic arthritis
First placebo-controlled randomized trial in active psoriatic arthritis... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
EVOTEC | 595 |
BAYER | 391 |
BYD | 327 |
NEL | 309 |
NVIDIA | 287 |
TESLA | 273 |
TUI | 273 |
DEUTSCHE BANK | 266 |
PLUG POWER | 266 |
SUPER MICRO COMPUTER | 248 |
APPLE | 237 |
RHEINMETALL | 230 |
RWE | 221 |
MERCEDES-BENZ | 204 |
DEUTSCHE LUFTHANSA | 201 |
AMAZON | 192 |
BERKSHIRE HATHAWAY | 189 |
RENK GROUP | 159 |
VOLKSWAGEN | 159 |
ALLIANZ | 155 |
COMMERZBANK | 151 |
BIONTECH | 150 |
AIXTRON SE | 149 |
PAYPAL | 149 |
BASF | 145 |